US Stock MarketDetailed Quotes
KANT Kineta
- 0.859
- +0.159+22.74%
15min DelayClose Sep 20 16:00 ET
- 0.859
- 0.0000.00%
Post 16:02 ET
10.54MMarket Cap-523P/E (TTM)
0.870High0.632Low245.67KVolume0.711Open0.700Pre Close184.03KTurnover3.08%Turnover RatioLossP/E (Static)12.26MShares5.39052wk High-1.29P/B6.86MFloat Cap0.33452wk Low--Dividend TTM7.98MShs Float702.947Historical High--Div YieldTTM33.99%Amplitude0.334Historical Low0.749Avg Price1Lot Size
About Kineta Company
Kineta, Inc. is a clinical-stage biotechnology company, which develops immunotherapies for cancer patients. Its immuno-oncology focused platform aims at developing fully human antibodies to address the major mechanisms of cancer immune resistance. The company was founded by Shawn P. Iadonato and Charles L. Magness in 2008 and is headquartered in Seattle, WA.
Company Profile
SymbolKANT
Company NameKineta
Listing DateFeb 11, 2016
Founded2008
MarketPink Market
Address219 Terry Avenue North,Suite 300
CitySeattle
ProvinceWashington
CountryUnited States of America
Zip Code98109
Phone1-206-378-0400
Websitehttp://www.kinetabio.com
Company Executives
No Data
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
